JMI Syringes & Medical Devices Ltd's profit grew nearly 13 per cent year-on-year in the last financial year. 

The manufacturer of precision safety syringes and medical devices clocked a profit of Tk 10 crore in 2021-22, against Tk 8.9 crore in the previous year.

Thus, the company reported earnings per share of Tk 4.55 for the year that ended on June 30, which was Tk 4.03 a year earlier.

Net asset value per share rose to Tk 124.25 from Tk 122.70 during the 12-month period.

Net operating cash flow per share, however, slipped to 1.85 against Tk 8.38 earlier.

The board of directors of JMI Syringes has recommended a 36 per cent stock dividend for 2021-22, according to a filing on the Dhaka Stock Exchange yesterday.

Shares of the company surged 10.98 per cent on the DSE yesterday.

A joint venture with an enterprise of South Korea, JMI exports its products to Singapore, Thailand, Myanmar, Spain, and Portugal, according to its website.